-
Product Insights
Clostridioides Difficile Infections (Clostridium Difficile Associated Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Clostridioides difficile Infections – Drugs In Development, 2022, provides an overview of the Clostridioides difficile Infections (Infectious Disease) pipeline landscape. Clostridium difficile infections are caused by Clostridium difficile, often called C. difficile or C. diff, a bacterium that can cause symptoms ranging from diarrhea to life-threatening inflammation of the colon. Symptoms of C. diff infection includes watery diarrhea, with abdominal pain or tenderness, loss of appetite, fever, blood or pus...
-
Product Insights
Streptococcus pyogenes Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Streptococcus pyogenes infections pipeline market research report provides comprehensive information on the therapeutics under development for streptococcus pyogenes Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Streptococcus pyogenes Infections and...
-
Product Insights
Anthrax Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Anthrax pipeline market research report provides comprehensive information on the therapeutics under development for Anthrax, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Anthrax and features dormant and discontinued projects.
-
Sector Analysis
Oil and Gas Shale in the United States of America (USA), 2021 – Market Analysis and Future Outlook
US shale producers remain disciplined with production and capital guidance despite high oil prices. The speed at which new rigs are put to new developments is considerably less than in previous price cycles. Most US shale producers are being conservative in their production and capital guidance, as priorities remain around protecting balance sheets and generating free cash flow. For many operators, this has led to a drawdown of drilled but uncompleted (DUC) inventory wells in the past six months, to...
-
Sector Analysis
Denver Julesburg (DJ) Basin in the Unites States of America (USA), 2021 – Oil and Gas Shale Market Analysis and Outlook to 2025
The Denver-Julesburg (DJ) Basin crude oil and condensate production was 491.4 mbd while the natural gas production was 5,058 mmcfd in 2020. The crude oil and natural gas production in the DJ Basin are projected to recover, bringing in positive market sentiment during the forecast period. The DJ Basin also referred to Denver Basin, Julesburg Basin, or DJ Basin, is crude oil and natural gas-rich formation located in Northeast Colorado and Southeast Wyoming. The formation also extends to some parts...
-
Analyst Opinions
Super League In-Depth Analysis: UBS 2016
UBS conducts its wealth management activities under two divisions: UBS Wealth Management and UBS Wealth Management Americas. UBS has a strong global presence and a broad client base – Asia Pacific being a key growth market. As measured by AUM, the Americas and EMEA are the biggest markets.